- Q1 2024 Kiniksa Pharmaceuticals Ltd Earnings Call TranscriptApr 23, 2024$17.68 (+3.42%)Earnings
- Q4 2023 Kiniksa Pharmaceuticals Ltd Earnings Call TranscriptFeb 28, 2024$20.36 (-2.54%)Earnings
- Kiniksa Pharmaceuticals Ltd at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Q3 2023 Kiniksa Pharmaceuticals Ltd Earnings Call TranscriptOct 31, 2023$15.25 (-2.74%)Earnings
- Q2 2023 Kiniksa Pharmaceuticals Ltd Earnings Call TranscriptJul 25, 2023$19.48 (+30.39%)Earnings
- Kiniksa Pharmaceuticals Ltd at Goldman Sachs Healthcare Conference TranscriptJun 13, 2023
- Q1 2023 Kiniksa Pharmaceuticals Ltd Earnings Call TranscriptMay 02, 2023$12.59 (+14.66%)Earnings
- Q4 2022 Kiniksa Pharmaceuticals Ltd Earnings Call TranscriptFeb 28, 2023$12.86 (-3.45%)Earnings
- Kiniksa Pharmaceuticals Ltd at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Kiniksa Pharmaceuticals Ltd at Bank of America Biotech SMID Cap Conference TranscriptDec 07, 2022
- Q3 2022 Kiniksa Pharmaceuticals Ltd Earnings Call TranscriptNov 01, 2022$12.8 (+12.08%)Earnings
- Q2 2022 Kiniksa Pharmaceuticals Ltd Earnings Call TranscriptAug 03, 2022$10.68 (+7.12%)Earnings
- Q1 2022 Kiniksa Pharmaceuticals Ltd Earnings Call TranscriptMay 03, 2022$10.11 (+7.44%)Earnings
- Q4 2021 Kiniksa Pharmaceuticals Ltd Earnings Call TranscriptFeb 22, 2022$10.62 (-0.93%)Earnings
- Kiniksa Pharmaceuticals Ltd at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Q3 2021 Kiniksa Pharmaceuticals Ltd Earnings Call TranscriptNov 01, 2021$12.73 (+22.52%)Earnings
- Q2 2021 Kiniksa Pharmaceuticals Ltd Earnings Call TranscriptAug 03, 2021$13.69 (-15.65%)Earnings
- Kiniksa Pharmaceuticals Ltd at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 08, 2021
- Kiniksa Pharmaceuticals Ltd FDA Approval of ARCALYST (rilonacept) for Recurrent Pericarditis Conference Call TranscriptMar 18, 2021
- Kiniksa Pharmaceuticals Ltd at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Kiniksa Pharmaceuticals Ltd Rilonacept Analyst Day TranscriptSep 29, 2020
- Kiniksa Pharmaceuticals Ltd at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 16, 2020
- Kiniksa Pharmaceuticals Ltd Annual Shareholders Meeting TranscriptJun 30, 2020
- Kiniksa Pharmaceuticals, Ltd. - Special Call TranscriptJun 29, 2020
- Kiniksa Pharmaceuticals Ltd at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 11, 2020
- Kiniksa Pharmaceuticals Ltd at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Kiniksa Pharmaceuticals Ltd at Goldman Sachs Global Healthcare Conference TranscriptJun 11, 2019
- Kiniksa Pharmaceuticals Ltd at Barclays Global Healthcare Conference TranscriptMar 12, 2019
Kiniksa Pharmaceuticals Ltd at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Hi. Good morning, everyone. We will continue with the next session, which is Kiniksa Pharmaceuticals. Please note that this session will be audio only. And with that, I'm pleased to turn it over to CEO, Sanj Patel, who will kick it off with some introductory remarks. Sanj?
Thanks, Paul. Good morning, and thanks, obviously, to Goldman Sachs for hosting us today. With me on the call are John Paolini, our Chief Medical Officer; Ross Moat, the ARCALYST General Manager and Head of Commercial; and Mark Ragosa, who's our Chief Financial Officer.
As always, please note that we will be making forward-looking statements today that are subject to both risks and uncertainties. A review of these statements and risk factors are found under the heading of Risk Factors in our SEC filings.
We are happy to have the opportunity today to discuss our recent approval and launch of ARCALYST in recurrent
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)